Product
TPM502
1 clinical trial
1 indication
Indication
Celiac DiseaseClinical trial
A Double-blind, Randomized, Placebo-controlled, Phase 2a Study to Evaluate the Safety, Tolerability, and Pharmacodynamic (PD) Effects of Two Infusions of Escalating Doses of TPM502 in Adults Diagnosed With Celiac DiseaseStatus: Recruiting, Estimated PCD: 2024-05-30